发明公开
- 专利标题： Glucagon-like peptide-2 analogs
- 专利标题（中）： 胰高血糖素肽-2的类似的模拟
-
申请号： EP10163303.0申请日： 1997-04-11
-
公开(公告)号： EP2218734A3公开(公告)日： 2010-10-13
- 发明人: Drucker, Daniel , Crivici, Anna , Sumner-Smith, Martin
- 申请人： 1149336 ONTARIO INC. , NPS Pharmaceuticals, Inc.
- 申请人地址： 19 Fernwood Road Toronto, Ontario M6B 3G3 CA
- 专利权人： 1149336 ONTARIO INC.,NPS Pharmaceuticals, Inc.
- 当前专利权人： 1149336 ONTARIO INC.,NPS Pharmaceuticals, Inc.
- 当前专利权人地址： 19 Fernwood Road Toronto, Ontario M6B 3G3 CA
- 代理机构： Maiwald Patentanwalts GmbH
- 优先权： US631273 19960412
- 主分类号： C07K14/605
- IPC分类号： C07K14/605 ; A61K38/26 ; G01N33/68
摘要：
Analogs of glucagon-like peptide-2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as a pharmaceutical for therapeutic use in treating disorders of the small bowel is described.
公开/授权文献
- EP2218734B1 Glucagon-like peptide-2 analogs 公开/授权日：2013-06-05
信息查询
